Genzyme: What Makes a Great Rare Disease Company.
19:00 EDT 27 Jul 2012 | PharmaTelevision
In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to David Meeker, President & CEO at Genzyme
Original Article: Genzyme: What Makes a Great Rare Disease Company.
More From BioPortfolio on "Genzyme: What Makes a Great Rare Disease Company."
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
